Krystal Biotech buy Jefferies Financial Group Inc.
Start price
17.02.26
/
50%
€245.60
Target price
17.02.27
-
Performance (%)
14.58%
Price
04.08.26
€281.40
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ currently has a performance of 14.58%. This prediction currently runs until 17.02.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -11.952% | -11.952% |
| iShares Core DAX® | 3.258% | 2.069% |
| iShares Nasdaq 100 | 5.697% | -0.604% |
| iShares Nikkei 225® | 7.770% | -4.746% |
| iShares S&P 500 | 2.795% | 2.251% |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€166.55
05.03.25
05.03.25
€228.54
05.03.26
05.03.26
34.31%
06.03.26
06.03.26
